ASCO

FLORHAM PARK, N.J., June 05, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted…

As previously reported, avasopasem reduced cisplatin-related chronic kidney disease by 50% compared to placebo at one-year follow-up Additional data demonstrated improved preservation of…

- Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab tazevibulin, or luvelta, in ovarian cancer,…

ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndromeA high proportion of patients had tumor biomarker reduction (77%) with 32% having complete…

- Marked increases in overall survival observed across soft tissue sarcoma patients - - Demonstrated improvement of median progression free survival in patients with dedifferentiated…

Lori Solomon FRIDAY, June 2, 2023 (HealthDay News) -- A telephone-based weight-loss coaching intervention can help overweight or obese patients…

Elana Gotkine FRIDAY, June 2, 2023 (HealthDay News) -- The microbiome (MB) of patients with colorectal cancer (CRC) varies between those…

WASHINGTON, June 02, 2023 (GLOBE NEWSWIRE) -- The Cancer Support Community (CSC), a nonprofit dedicated to uplifting and strengthening people impacted by cancer, has partnered with Equiva…

Elana Gotkine THURSDAY, June 1, 2023 (HealthDay News) -- For women with persistent, recurrent, or metastatic cervical cancer, adding…

芝加哥, May 29, 2023 (GLOBE NEWSWIRE) -- Novotech 是亚太地区领先的生物技术 CRO，为美国临床肿瘤学会议 (ASCO) 的两项聚焦肿瘤学的关键专家活动提供赞助。这两项活动分别是与 eChina Health 合办的 pre-ASCO 峰会和与 Endpoints 共同召开的、以加速开发先进疗法为主题的网络研讨会小组讨论。…